Hematology-Oncology Associates of the Quad-Cities, PC
Carcinoid Cancer Trials
SWOG S0518: Phase III Prospective Randomized Comparison of Depot Octreotide Plus Interferon Alpha Versus Depot Octreotide Plus Bevacizumab in Advanced, Poor Prognosis Carcinoid Patients
